Skip to main content

WELLS FARGO & COMPANY/MN

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in PLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$157,388
+$99,836 QoQ
Shares Held
67,549
+154.7% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 101 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. PLX ranks #269 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $157,388 67,549
2026-03-31 $57,552 26,522
2025-12-31 $142,202 79,002
2025-09-30 $95,084 42,831
2025-06-30 $53,329 36,034
2024-03-31 $29,444 23,369
2023-12-31 $35,475 19,930
2023-09-30 $26,427 15,920
2023-06-30 $41,988 20,994